ReversIBLe,competitiveinhibitorofsterolregulatoryelement-bindingprotein(SREBP)site1protease(IC50=0.175μM).Selectiveforsite1proteaseagainstapanelofserineproteases.InhibitsrateofcholesterolsynthesisinCHOcells(IC50=0.53μM).Alsodisplaysantiviralactivity.Cellpermeable.
SoldforresearchpurposesunderagreementfromPfizerInc.
PF429242isalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight482.49.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.